Arbutus Biopharma Corp
NASDAQ:ABUS

Watchlist Manager
Arbutus Biopharma Corp Logo
Arbutus Biopharma Corp
NASDAQ:ABUS
Watchlist
Price: 4.79 USD 2.35% Market Closed
Market Cap: 921.2m USD

Intrinsic Value

The intrinsic value of one ABUS stock under the Base Case scenario is hidden USD. Compared to the current market price of 4.79 USD, Arbutus Biopharma Corp is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

ABUS Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Arbutus Biopharma Corp

Intrinsic Value History
Dive into the past to invest in the future

ABUS looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether ABUS usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about ABUS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ABUS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Arbutus Biopharma Corp.

Explain Valuation
Compare ABUS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ABUS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Arbutus Biopharma Corp

Current Assets 97.4m
Cash & Short-Term Investments 93.7m
Receivables 905k
Other Current Assets 2.8m
Non-Current Assets 268k
PP&E 137k
Other Non-Current Assets 131k
Current Liabilities 5.2m
Accounts Payable 1m
Accrued Liabilities 3.4m
Other Current Liabilities 763k
Non-Current Liabilities 15.1m
Other Non-Current Liabilities 15.1m
Efficiency

Free Cash Flow Analysis
Arbutus Biopharma Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Arbutus Biopharma Corp

Revenue
14.6m USD
Operating Expenses
-48.7m USD
Operating Income
-34.1m USD
Other Expenses
-8.2m USD
Net Income
-42.3m USD
Fundamental Scores

ABUS Profitability Score
Profitability Due Diligence

Arbutus Biopharma Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Declining Net Margin
Low Gross Margin
hidden
Profitability
Score

Arbutus Biopharma Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ABUS Solvency Score
Solvency Due Diligence

Arbutus Biopharma Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Arbutus Biopharma Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABUS Price Targets Summary
Arbutus Biopharma Corp

Wall Street analysts forecast ABUS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABUS is 5.78 USD with a low forecast of 5.05 USD and a high forecast of 7.35 USD.

Lowest
Price Target
5.05 USD
5% Upside
Average
Price Target
5.78 USD
21% Upside
Highest
Price Target
7.35 USD
53% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Arbutus Biopharma Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for ABUS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ABUS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ABUS stock?

The intrinsic value of one ABUS stock under the Base Case scenario is hidden USD.

Is ABUS stock undervalued or overvalued?

Compared to the current market price of 4.79 USD, Arbutus Biopharma Corp is hidden .

Back to Top